Comparison of the Effect of Liraglutide in Young Versus Elderly Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

June 30, 2004

Study Completion Date

June 30, 2004

Conditions
DiabetesHealthy
Interventions
DRUG

liraglutide

A single dose of 1 mg administered subcutaneously (under the skin)

Trial Locations (1)

14050

Novo Nordisk Investigational Site, Berlin

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY